Hua Naranmandura

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 20

Top Topics

Acute Lymphoblastic Leukemia

Magnetic Nanoparticles

Respiratory Syndrome Coronavirus

Top Venues

Expert opinion on drug discovery

Bioengineering (Basel, Switzerland)

Metallomics : integrated biometal science

Biotechnology and applied biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming, Hua Naranmandura
Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets. Expert opinion on drug discovery 18 (3) (2023)
Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming, Hua Naranmandura
Targeting Viral Proteins for Restraining SARS-CoV-2: Focusing Lens on Viral Proteins Beyond Spike for Discovering New Drug Targets. Expert opinion on drug discovery (2023)
Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming, Hua Naranmandura
Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets. Expert opinion on drug discovery 18 (3) (2023)
Pierre Bercier, Qian Qian Wang, Ning Zang, Jie Zhang, Chang Yang, Yasen Maimaitiyiming, Majdouline Abou-Ghali, Caroline Berthier, Chengchen Wu, Michiko Niwa-Kawakita, Thassadite Dirami, Marie-Claude Geoffroy, Omar Ferhi, Samuel Quentin, Shirine Benhenda, Yasumitsu Ogra, Zoher Gueroui, Chun Zhou, Hua Naranmandura, Hugues de Thé, Valerie Lallemand-Breitenbach
Structural basis of PML/RARA oncoprotein targeting by arsenic unravels a cysteine rheostat controlling PML body assembly and function. Cancer discovery (2023)
Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming, Hua Naranmandura
Targeting Viral Proteins for Restraining SARS-CoV-2: Focusing Lens on Viral Proteins Beyond Spike for Discovering New Drug Targets. Expert opinion on drug discovery (2023)
Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming, Hua Naranmandura
Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets. Expert opinion on drug discovery 18 (3) (2023)
Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming, Hua Naranmandura
Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets. Expert opinion on drug discovery 18 (3) (2023)
Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming, Hua Naranmandura
Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets. Expert opinion on drug discovery (2023)
Si Chun Wang, Xing Yi Yan, Chang Yang, Hua Naranmandura
The Landscape of Nucleic-Acid-Based Aptamers for Treatment of Hematologic Malignancies: Challenges and Future Directions. Bioengineering (Basel, Switzerland) 9 (11) (2022)
Yasen Maimaitiyiming, Tao Yang, Qian Qian Wang, Yan Feng, Zhi Chen, Mikael Björklund, Fudi Wang, Chonggao Hu, Chih-Hung Hsu, Hua Naranmandura
Heat Treatment Promotes Ubiquitin-Mediated Proteolysis of SARS-CoV-2 RNA Polymerase and Decreases Viral Load. Research (Washington, D.C.) 2022 (2022)
Qian Qian Wang, Hua-Feng Wang, Jian-Zhi Zhao, Hua Naranmandura, Jie Jin, Hong Hu Zhu
Venetoclax for arsenic-resistant acute promyelocytic leukaemia. British journal of haematology 197 (5) (2022)
Huafeng Wang, Chang Yang, Ting Shi, Yi Zhang, Jiejing Qian, Yungui Wang, Yongxian Hu, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong Hu Zhu
Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia. Blood cancer journal 12 (1) (2022)
Ming Hua Ge, Xu Hang Zhu, Yi Ming Shao, Chao Wang, Ping Huang, Yun Wang, Yu Jiang, Yasen Maimaitiyiming, En Chen, Chang Yang, Hua Naranmandura
Synthesis and characterization of CD133 targeted aptamer-drug conjugates for precision therapy of anaplastic thyroid cancer. Biomaterials science 9 (4) (2021)
Xuqiao Hu, Hongyan Li, Tiffany Ka-Yan Ip, Yam Fung Cheung, Mohamad Koohi-Moghadam, Haibo Wang, Xinming Yang, Daniel N Tritton, Yuchuan Wang, Yi Wang, Runming Wang, Kwan-Ming Ng, Hua Naranmandura, Eric Wai-Choi Tse, Hongzhe Sun
Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin. Chemical science 12 (32) (2021)
Chang Yang, Yu Jiang, Sai Heng Hao, Xing Yi Yan, De Fei Hong, Hua Naranmandura
Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy. Journal of materials chemistry. B (2021)
Yasen Maimaitiyiming, Hong-Hu Zhu, Chang Yang, Hua Naranmandura
Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts. Drug metabolism reviews 52 (3) (2020)
Chang Yang, Rui Hao, Yong Fei Lan, Ye Jia Chen, Chao Wang, Na Bu, Qian Qian Wang, Liaqat Hussain, Li Ya Ma, Yasen Maimaitiyiming, Xiao Yang Lu, Hua Naranmandura
Integrity of zinc finger motifs in PML protein is necessary for inducing its degradation by antimony. Metallomics : integrated biometal science 11 (8) (2019)
Yasen Maimaitiyiming, Chang Yang, Yun Wang, Liaqat Hussain, Hua Naranmandura
Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco-2 cells. Biotechnology and applied biochemistry 66 (3) (2019)
Yasen Maimaitiyiming, De Fei Hong, Chang Yang, Hua Naranmandura
Novel insights into the role of aptamers in the fight against cancer. Journal of cancer research and clinical oncology 145 (4) (2019)
Liaqat Hussain, Yasen Maimaitiyiming, Li De Su, Qian Qian Wang, Hua Naranmandura
Phenylarsine Oxide Can Induce Degradation of PLZF-RARα Variant Fusion Protein of Acute Promyelocytic Leukemia. Chemical research in toxicology 32 (4) (2019)